Cargando…

S100A8 and S100A12 Proteins as Biomarkers of High Disease Activity in Patients with Rheumatoid Arthritis That Can Be Regulated by Epigenetic Drugs

Rheumatoid arthritis (RA) is an autoimmune chronic inflammatory disease that is still not well understood in terms of its pathogenesis and presents diagnostic and therapeutic challenges. Monocytes are key players in initiating and maintaining inflammation through the production of pro-inflammatory c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roszkowski, Leszek, Jaszczyk, Bożena, Plebańczyk, Magdalena, Ciechomska, Marzena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9820830/ https://www.ncbi.nlm.nih.gov/pubmed/36614150 http://dx.doi.org/10.3390/ijms24010710

Ejemplares similares

Biologic Drugs for Rheumatoid Arthritis in the Context of Biosimilars, Genetics, Epigenetics and COVID-19 Treatment
por: Bonek, Krzysztof, et al.
Publicado: (2021)

Tuning Monocytes and Macrophages for Personalized Therapy and Diagnostic Challenge in Rheumatoid Arthritis
por: Roszkowski, Leszek, et al.
Publicado: (2021)

DNA Methylation as a Future Therapeutic and Diagnostic Target in Rheumatoid Arthritis
por: Ciechomska, Marzena, et al.
Publicado: (2019)

Humoral and cellular immunogenicity of COVID-19 booster dose vaccination in inflammatory arthritis patients
por: Wroński, Jakub, et al.
Publicado: (2022)

The Kinetics of Humoral and Cellular Responses after the Booster Dose of COVID-19 Vaccine in Inflammatory Arthritis Patients
por: Wroński, Jakub, et al.
Publicado: (2023)

Circulating miRNA-19b as a biomarker of disease progression and treatment response to baricitinib in rheumatoid arthritis patients through miRNA profiling of monocytes
por: Ciechomska, Marzena, et al.
Publicado: (2023)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
por: Bonek, Krzysztof, et al.
Publicado: (2022)

From bench to bedside: Calprotectin (S100A8/S100A9) as a biomarker in rheumatoid arthritis
por: Inciarte-Mundo, José, et al.
Publicado: (2022)

CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis
por: Wang, Zhi-wen, et al.
Publicado: (2022)

Retracted: CKS2 and S100A12: Two Novel Diagnostic Biomarkers for Rheumatoid Arthritis
por: Markers, Disease
Publicado: (2023)

Role of the S100 protein family in rheumatoid arthritis
por: Wu, Yuan-yuan, et al.
Publicado: (2022)

Small Molecule Inhibitors in the Treatment of Rheumatoid Arthritis and Beyond: Latest Updates and Potential Strategy for Fighting COVID-19
por: Massalska, Magdalena, et al.
Publicado: (2020)

Calprotectin (S100A8/S100A9) detects inflammatory activity in rheumatoid arthritis patients receiving tocilizumab therapy
por: Gernert, Michael, et al.
Publicado: (2022)

S100A8/A9 as a biomarker for synovial inflammation and joint damage in patients with rheumatoid arthritis
por: Kang, Kwi Young, et al.
Publicado: (2014)

Impact of Adipose-Derived Mesenchymal Stem Cells (ASCs) of Rheumatic Disease Patients on T Helper Cell Differentiation
por: Kuca-Warnawin, Ewa, et al.
Publicado: (2022)

Potential Mechanism of Fatigue Induction and Its Management by JAK Inhibitors in Inflammatory Rheumatic Diseases
por: Felis-Giemza, Anna, et al.
Publicado: (2023)

Increased Plasma Levels of S100A8, S100A9, and S100A12 in Chronic Spontaneous Urticaria
por: Zhou, Qiong-Yan, et al.
Publicado: (2019)

S-100 Proteins: Basics and Applications as Biomarkers in Animals with Special Focus on Calgranulins (S100A8, A9, and A12)
por: Cerón, José Joaquín, et al.
Publicado: (2023)

Epigenetic Regulation of S100A9 and S100A12 Expression in Monocyte-Macrophage System in Hyperglycemic Conditions
por: Mossel, Dieuwertje M., et al.
Publicado: (2020)

Circulating calprotectin (S100A8/A9) is higher in rheumatoid arthritis patients that relapse within 12 months of tapering anti-rheumatic drugs
por: de Moel, Emma C., et al.
Publicado: (2019)

Serum calprotectin (S100A8/9): an independent predictor of ultrasound synovitis in patients with rheumatoid arthritis
por: Hurnakova, Jana, et al.
Publicado: (2015)

Secretion of S100A8, S100A9, and S100A12 by Neutrophils Involves Reactive Oxygen Species and Potassium Efflux
por: Tardif, Mélanie R., et al.
Publicado: (2015)

Top 100 cited articles on rheumatoid arthritis: A bibliometric analysis
por: Yin, Xiangjun, et al.
Publicado: (2019)

S-Calprotectin (S100A8/S100A9): A Potential Marker of Inflammation in Patients with Psoriatic Arthritis
por: Hansson, Claes, et al.
Publicado: (2014)

C/EBPδ-induced epigenetic changes control the dynamic gene transcription of S100a8 and S100a9
por: Jauch-Speer, Saskia-Larissa, et al.
Publicado: (2022)

Epigenetic regulation of S100 protein expression
por: Leśniak, Wiesława
Publicado: (2011)

S100A8 and S100A9 in experimental osteoarthritis
por: Zreiqat, Hala, et al.
Publicado: (2010)

Alarmin S100A8/S100A9 as a biomarker for molecular imaging of local inflammatory activity
por: Vogl, Thomas, et al.
Publicado: (2014)

Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis
por: Müller, Irene, et al.
Publicado: (2020)

Enhanced myelopoiesis and aggravated arthritis in S100a8-deficient mice
por: Cesaro, Annabelle, et al.
Publicado: (2019)

Identification of S100A9 as Biomarker of Responsiveness to the Methotrexate/Etanercept Combination in Rheumatoid Arthritis Using a Proteomic Approach
por: Obry, Antoine, et al.
Publicado: (2014)

Changes in MiRNA-5196 Expression as a Potential Biomarker of Anti-TNF-α Therapy in Rheumatoid Arthritis and Ankylosing Spondylitis Patients
por: Ciechomska, Marzena, et al.
Publicado: (2018)

High plasma level of S100A8/S100A9 and S100A12 at admission indicates a higher risk of death in septic shock patients
por: Dubois, Christelle, et al.
Publicado: (2019)

Tissue mRNA for S100A4, S100A6, S100A8, S100A9, S100A11 and S100P Proteins in Colorectal Neoplasia: A Pilot Study
por: Peterova, Eva, et al.
Publicado: (2021)

Epigenetic Modulation as a Therapeutic Prospect for Treatment of Autoimmune Rheumatic Diseases
por: Ciechomska, Marzena, et al.
Publicado: (2016)

The potential pathogenic roles of S100A8/A9 and S100A12 in patients with MPO-ANCA-positive vasculitis
por: Bai, Xue, et al.
Publicado: (2022)

100 años de cine, 100 películas, 100 directores, 100 actrices, 100 actores
por: Torres, Augusto M.
Publicado: (1995)

Expression of Calgranulin Genes S100A8, S100A9 and S100A12 Is Modulated by n-3 PUFA during Inflammation in Adipose Tissue and Mononuclear Cells
por: Shah, Rachana D., et al.
Publicado: (2017)

S100A12 is a promising biomarker in papillary thyroid cancer
por: Wang, Xiaojie, et al.
Publicado: (2020)

Crosslinking of microtubules and actin filaments by S100A8/S100A9
por: Wolf, M, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_s8rl8t9tlgvjuj87ks9v0ismqq